<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Microsatellite instability (MSI) is a distinct molecular phenotype of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> related to prognosis and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> response to <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU)-based chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the differential impact of MSI between colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> as a marker of prognosis and chemotherapeutic response </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: PCR-based MSI assay was performed on 1125 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Six hundred and sixty patients (58.7%) had <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and 465 patients (41.3%) had <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Among 1125 patients, 106 (9.4%) had high-frequency MSI (MSI-H) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>MSI-H <z:hpo ids='HP_0003003'>colon cancers</z:hpo> (13%) had distinct phenotypes including young age at diagnosis, family history of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, early <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>, Node, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e> (TNM) stage, proximal location, poor differentiation, and high level of baseline carcinoembryonic antigen (CEA), while MSI-H <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> (4.3%) showed similar clinicopathological characteristics to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/MSI-L <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> except for family history of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were strongly correlated with longer disease free survival (DFS) (P=0.005) and overall survival (OS) (P=0.009) than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/MSI-L <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, while these positive correlations were not observed in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/MSI-L <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> receiving 5-FU-based chemotherapy showed good prognosis (P=0.013), but this positive association was not observed in MSI-H (P=0.104) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These results support the use of MSI status as a marker of prognosis and response to 5-FU-based chemotherapy in patients with <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Further study is mandatory to evaluate the precise role of MSI in patients with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> and the effect of 5-FU-based chemotherapy in MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
</text></document>